| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.63M | 12.04M | 9.30M | 8.17M | 7.39M |
| Gross Profit | 2.91M | 3.64M | 2.17M | 1.44M | 1.64M |
| EBITDA | -114.00K | 804.47K | -521.60K | -2.31M | -1.85M |
| Net Income | -979.00K | -46.72K | -953.16K | -2.50M | -2.17M |
Balance Sheet | |||||
| Total Assets | 6.27M | 8.32M | 8.33M | 7.07M | 8.54M |
| Cash, Cash Equivalents and Short-Term Investments | 723.00K | 1.21M | 981.36K | 590.67K | 3.86M |
| Total Debt | 1.67M | 1.93M | 2.37M | 2.94M | 2.51M |
| Total Liabilities | 4.71M | 5.84M | 5.87M | 5.13M | 4.62M |
| Stockholders Equity | 1.14M | 2.08M | 2.10M | 1.59M | 3.59M |
Cash Flow | |||||
| Free Cash Flow | 399.00K | 1.51M | -451.82K | -3.38M | -2.29M |
| Operating Cash Flow | 519.00K | 1.53M | 175.57K | -2.75M | -1.98M |
| Investing Cash Flow | -517.00K | -577.66K | -457.42K | -627.37K | -305.05K |
| Financing Cash Flow | -494.00K | -723.18K | 672.54K | 110.41K | 6.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £67.15M | 3.57 | 22.93% | ― | 136.76% | ― | |
72 Outperform | £3.78B | 17.58 | 8.06% | 2.12% | 4.99% | -24.08% | |
67 Neutral | £253.45M | 25.56 | 3.10% | 2.19% | 10.66% | 23.08% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £329.69M | 135.40 | 6.24% | 1.89% | 9.13% | -47.18% | |
55 Neutral | £22.34M | -4.97 | ― | ― | ― | ― | |
54 Neutral | £210.48M | -1.27 | -31.21% | ― | -7.62% | 5.48% |